GeneDx Holdings Corp. Faces Securities Class Action Lawsuit Amid Sharp Share Price Decline
Shares of GeneDx Holdings Corp (NASDAQ: WGS) dropped by $33.42, or nearly 50%, following a significant impairment charge and revised revenue guidance. Institutional investors are being alerted to potential fiduciary obligations due to the decline.

Tickers: $WGS
Topics: class action fiduciary obligations investor losses stock price decline